Live Breaking News & Updates on Summit Therapeutics Inc Stock Exchange

Stay updated with breaking news from Summit therapeutics inc stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

NEW YORK, June 5, 2023 /PRNewswire/ Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty. | June 5, 2023 ....

Roberth Lefkowitz , Purcell Lefkowitz , Summit Therapeutics Inc , Prnewswire Purcell Lefkowitz , Summit Therapeutics , Summit Therapeutics Inc Stock Exchange , Press Release , Iduciary Smmt Us86627t1088 ,

Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023

Data Supporting Summit’s Planned Phase III Trial for First-line Metastatic Squamous NSCLC Patients on Display

Phase II ORR of 67% with a mDOR of 15 months in 1L SQ-NSCLC Patients

. | June 4, 2023 ....

Li Zhang , Yu Zhang , United States , United Kingdom , Li Zhuang , Ming Zhou , Wu Zhuang , Menlo Park , Yuanyuan Zhao , Michelle Xia , Likun Chen , Yanqiu Zhao , Qitao Yu , Jianhua Chen , Bryan Huang , Yunpeng Yang , Ningning Zhou , Weidong Zhang , Wenfeng Fang , American Cancer Society , Summit Therapeutics Inc , American Society Of Clinical Oncology , Drug Administration , Team Summit , Exchange Commission , Summit Therapeutic Mission Statement ,

Ivonescimab Updated Data to be Featured at ASCO 2023

Summit Therapeutics is Currently Enrolling in a Phase III Study with Additional Phase III Study Planned for Third Quarter 2023 for Ivonescimab

. | June 1, 2023 ....

Li Zhang , United Kingdom , Yu Zhang , Menlo Park , United States , Ming Zhou , Li Zhuang , Wu Zhuang , Weidong Zhang , Bryan Huang , Jianhua Chen , Qitao Yu , Yanqiu Zhao , Michelle Xia , Yuanyuan Zhao , Ningning Zhou , Wenfeng Fang , Yunpeng Yang , Likun Chen , World Health Organization , Exchange Commission , Summit Therapeutics Inc , Team Summit , Summit Therapeutic Mission Statement , Drug Administration , American Cancer Society ,

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023

First US Patient Treated in Ivonescimab Clinical Trial after Closing Agreement; $500M Raised in Fully-Subscribed Rights Offering

. | May 11, 2023 ....

United Kingdom , United States , Menlo Park , Maky Zanganeh , Robertw Duggan , Yu Michelle Xia , Crown Bioscience , Biopharma Inc , Company Board Of Directors , Celera Genomics Inc , Team Summit , Summit Therapeutic Mission Statement , Summit Therapeutics Inc , Bayer Corporation , Abbvie Inc , Company Co , Axys Pharmaceuticals Inc , Drug Administration , Crown Bioscience Inc , Exchange Commission , Forbe Powerful Women In Technology , Akeso Inc , Us Food Drug Administration , Crown Asian Cancer Research Centre , Summit Therapeutics , License Agreement ,

Summit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab (SMT112)

Phase III Study Designed to Establish the Effect of Ivonescimab in Lung Cancer Patients Whose Tumors Progressed after EGFR-TKI Therapy

. | May 9, 2023 ....

Menlo Park , United States , United Kingdom , Maky Zanganeh , Ian Anderson , Robertw Duggan , Oncologist At Providence Medical Foundation , American Cancer Society , Team Summit , World Health Organization , Akeso Inc , Summit Therapeutic Mission Statement , Summit Therapeutics Inc , Summit Therapeutics , United States Based , Medical Oncologist , Providence Medical Foundation , Institutional Review Board , Cancer Society , Lung Cancer Statistics , Show Common , Health Organization , Nasdaq Global Market , Summit Therapeutics Inc Stock Exchange , Press Release , Fter Smmt Us86627t1088 ,